Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00220207 · ClinicalTrials.gov registry record · NA

Determining the Effect on Patients of Internet-Based Diabetes Disease Management

A NA study of Diabetes Mellitus, Type 2, sponsored by Robert Wood Johnson Foundation.

Completed
Registry status
NA
Development phase
63
Enrollment target
1
Study location

NCT00220207: Completed NA study of Diabetes Mellitus, Type 2, sponsored by Robert Wood Johnson Foundation.

NCT00220207 is a NA study of Diabetes Mellitus, Type 2 that has completed, run by Robert Wood Johnson Foundation. The registered enrollment target is 63 participants, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00220207, a NA study of Diabetes Mellitus, Type 2, has completed, sponsored by Robert Wood Johnson Foundation.

COMPLETED
Registry status
NA
Development phase
63 participants
Enrollment target
1
Study location

Study Summary

This grant supports a 12-month randomized controlled trial comparing usual care versus collaborative disease management over the Internet among disadvantaged African-Americans with Type 2 diabetes. The project aims to: (1) determine the effect of case-managed, Web-based diabetes care on glycemic control, health care utilization, self-efficacy, and patient satisfaction; and (2) qualitatively identify enablers of the successful use of computers, the Internet, and e-Health applications by disadvantaged patients.

Conditions Studied

Interventions

  • BEHAVIORAL Internet co-management module

Study Locations (1)

Washington

  • Harborview Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2003-09
Est. Completion 2007-02
Phase NA
Robert Wood Johnson Foundation

14 total trials

What the finished NCT00220207 record still lists

NCT00220207 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 63 participants, a relatively small participant target, below the 4,485-participant average among 348 other Diabetes Mellitus, Type 2 trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Diabetes Mellitus, Type 2 appearing as the primary indexed condition, and to 1 intervention - of which Internet co-management module is the first listed.

NCT00220207 reports a single indexed study location in Washington.

Frequently Asked Questions

What is clinical trial NCT00220207 about?

NCT00220207 is a clinical study titled "Determining the Effect on Patients of Internet-Based Diabetes Disease Management". This grant supports a 12-month randomized controlled trial comparing usual care versus collaborative disease management over the Internet among disadvantaged African-Americans with Type 2 diabetes. The project aims to: (1) determine the effect of case-managed, Web-based diabetes care on glycemic con...

What is the current status of trial NCT00220207?

This trial is currently completed. It is a NA study. The enrollment target is 63 participants. The study started on 2003-09. Estimated completion is 2007-02.

What conditions does trial NCT00220207 study?

This clinical trial studies the following conditions: Diabetes Mellitus, Type 2.

What interventions are being tested in trial NCT00220207?

The interventions under investigation include: Internet co-management module (BEHAVIORAL).

Who is sponsoring clinical trial NCT00220207?

This trial is sponsored by Robert Wood Johnson Foundation, which has 14 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00220207 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Diabetes Mellitus, Type 2

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00220207's enrollment target sits among peer trials

63 237th of 348 higher than 110 of 348 other Diabetes Mellitus, Type 2 trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Diabetes Mellitus, Type 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT03383575 · 63 participants · Phase 2

    Azacitidine and Enasidenib in Treating Patients With IDH2-Mutant Myelodysplastic Syndrome

  • NCT04870944 · 63 participants · Phase 1

    CBL0137 for the Treatment of Relapsed or Refractory Solid Tumors, Including CNS Tumors and Lymphoma

  • NCT05031897 · 63 participants · Phase 2

    Two Step Haplo With Radiation Conditioning

  • NCT05312671 · 63 participants · Phase 2

    Atezolizumab Plus Etoposide and Platinum in Small Cell Bladder Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00220207, the US trial registry maintained by the National Library of Medicine. NCT00220207 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.